Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
9.41
-0.02 (-0.21%)
At close: Nov 26, 2025, 4:00 PM EST
9.30
-0.11 (-1.17%)
After-hours: Nov 26, 2025, 6:38 PM EST

DAWN Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-151.76-95.5-188.92-142.18-70.65-40.51
Upgrade
Depreciation & Amortization
3.552.030.380.530.20.16
Upgrade
Asset Writedown & Restructuring Costs
-553-8-
Upgrade
Loss (Gain) From Sale of Investments
-15.35-6.39-10.08-2.03--
Upgrade
Stock-Based Compensation
44.3648.2639.3427.2413.320.53
Upgrade
Other Operating Activities
--108---2.1126.69
Upgrade
Change in Accounts Receivable
-8-13.88----
Upgrade
Change in Inventory
-4.19-3.24----
Upgrade
Change in Accounts Payable
2.760.692.32-1.481.540.13
Upgrade
Change in Unearned Revenue
0.754.79----
Upgrade
Change in Other Net Operating Assets
8.238.137.18.051.15-0.49
Upgrade
Operating Cash Flow
-119.62-78.11-146.85-109.87-48.54-13.49
Upgrade
Capital Expenditures
-1.74-2.17-0.22-0.03--0.09
Upgrade
Sale (Purchase) of Intangibles
-3.5-72.1-3--8-
Upgrade
Investment in Securities
-257.26-264.73131.6-255.05--
Upgrade
Other Investing Activities
-108----
Upgrade
Investing Cash Flow
-262.47-230.99128.38-255.07-8-0.09
Upgrade
Issuance of Common Stock
2.6182.35164165.9167.36-
Upgrade
Other Financing Activities
-20.94----
Upgrade
Financing Cash Flow
2.6203.29164165.9297.1229.98
Upgrade
Net Cash Flow
-379.49-105.82145.52-199.05240.5816.4
Upgrade
Free Cash Flow
-121.36-80.28-147.08-109.9-48.54-13.58
Upgrade
Free Cash Flow Margin
-90.79%-61.21%----
Upgrade
Free Cash Flow Per Share
-1.18-0.86-1.84-1.68-1.31-2.46
Upgrade
Cash Income Tax Paid
6.331.9----
Upgrade
Levered Free Cash Flow
-59.99-133.99-82.72-56.86-37.01-9.6
Upgrade
Unlevered Free Cash Flow
-59.99-133.99-82.72-56.86-37.01-9.58
Upgrade
Change in Working Capital
-0.4926.489.426.562.7-0.36
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q